Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol versus propofol with remifentanil in non-intubated intravenous general anesthesia for hysteroscopic surgery
ChiCTR2600134261Phase 4Not yet recruiting
- Sponsor
- Zhenjiang First People's Hospital
- Start
- Aug 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ciprofol, propofol and remifentanil (2 arms), sponsored by Zhenjiang First People's Hospital. Primary endpoint: Incidence of hypoxemia. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
ciprofolpropofolremifentanil
Beyond the preview
Go deeper on ChiCTR2600134261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600134261.